Heron Therapeutics HRTX
NASDAQ HRTX
$0.31 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Total Non-Current Liabilities (2022 - 2026)

Updated

Heron Therapeutics' Total Non-Current Liabilities came in at $240.3 million for Q2 2026, down 7.1% from $258.6 million a year earlier but up 3.5% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Heron Therapeutics' Total Non-Current Liabilities was $236.74 million, down 11.1% from FY2024.

  • Total Non-Current Liabilities carries a three-year compound annual growth rate of -0.1% (FY2022 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $266.18 million in FY2024 (+3.9%), $256.24 million in FY2023 (+8.1%) and $237.14 million in FY2022.
  • The five-year range for quarterly Total Non-Current Liabilities is $229.37 million (Q3 2025) to $266.18 million (Q4 2024).
  • Year-over-year, Total Non-Current Liabilities has declined for four consecutive quarters, with an average decline of 3.8% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2024 (growth of 8.3%), and the weakest in Q3 2025 (a decline of 12.0%).
  • Business Quant data shows HRTX's Total Non-Current Liabilities at $232.15 million (Q1 2026), $236.74 million (Q4 2025) and $229.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn 240.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240.30 Mn
Mar 31, 2026 232.15 Mn
Dec 31, 2025 236.74 Mn
Sep 30, 2025 229.37 Mn
Jun 30, 2025 258.60 Mn
Mar 31, 2025 263.52 Mn
Dec 31, 2024 266.18 Mn
Sep 30, 2024 260.54 Mn
Jun 30, 2024 255.84 Mn
Mar 31, 2024 251.41 Mn
Dec 31, 2023 256.24 Mn
Sep 30, 2023 256.74 Mn
Jun 30, 2023 240.27 Mn
Mar 31, 2023 232.07 Mn
Dec 31, 2022 237.14 Mn
Sep 30, 2022 249.26 Mn
Jun 30, 2022 265.46 Mn
Mar 31, 2022 249.52 Mn
API Access

Heron Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=HRTX&period=max&api_key=YOUR_API_KEY